Ecto-nucleotidase pathway is altered by different treatments with fluoxetine and nortriptyline.

@article{Pedrazza2008EctonucleotidasePI,
  title={Ecto-nucleotidase pathway is altered by different treatments with fluoxetine and nortriptyline.},
  author={Eduardo Luiz Pedrazza and Eduardo Pacheco Rico and Mario R. Senger and Leonardo Pedrazza and Fernanda Francine Zimmermann and Jo{\~a}o Jos{\'e} de Freitas Sarkis and Maur{\'i}cio Reis Bogo and Carla Denise Bonan},
  journal={European journal of pharmacology},
  year={2008},
  volume={583 1},
  pages={18-25}
}
Depression is one of the most disabling diseases and causes a significant burden to both individual and society. Selective serotonin reuptake inhibitors and tricyclic antidepressants, such as fluoxetine and nortriptyline, respectively, are commonly used in treatment for depression. These antidepressants were tested on cerebral cortex and hippocampal… CONTINUE READING